Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis

NCT00210340 is registered in ClinicalTrials.gov with International Extranodal Lymphoma Study Group (IELSG) as lead sponsor.

NCT NCT00210340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00210340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis
Lead sponsor
International Extranodal Lymphoma Study Group (IELSG)
Phase
Phase 1
Overall status
Withdrawn
Start date
Not reported
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, b cell